FCA
IBB icon

Fortis Capital Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Fortis Capital Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-354
Closed -$45.7K – 340
2023
Q1 		$45.7K Sell
354
-690
-66% -$90.3K 0.02% 294
2022
Q4 		$137K Buy
+1,044
New +$135K 0.08% 159

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Fortis Capital Advisors's IBB Position: Q2 2023 in Review

Fortis Capital Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 354 shares — an estimated $45.7K sold.

Fortis Capital Advisors first reported a position in IBB in Q4 2022 and held it in 2 quarters. The position peaked at $137K in Q4 2022. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

  • Fortis Capital Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
  • Fortis Capital Advisors sold 354 iShares Biotechnology ETF shares in Q2 2023, an estimated $45.7K.
  • Fortis Capital Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 2 quarters.
  • Fortis Capital Advisors's iShares Biotechnology ETF position peaked at $137K in Q4 2022.
  • 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Fortis Capital Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.